BIAF

bioAffinity Technologies, Inc.

8.05 USD

Last updated Sep 12, 01:35 UTC

Yesterday HIGH

$10.49

Yesterday LOW

$9.38

52w HIGH

$202.5

52w LOW

$4.56

EPS

-9.60

PE

-0.84

Next Earnings

Nov 13, 2026

Overview News Government Trades Fundamentals

bioAffinity Technologies, Inc. stock is up 39.91% since 30 days ago. The next earnings date is Nov 13, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 4 September’s closed higher than August.

Avi Kapoor

Tue Sep 1, 2026

Crude Oil Surges 3%; ISM Manufacturing PMI Falls In August

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Tuesday.The Dow traded down 0.40% to 52,971.81 while the NASDAQ dipped 0.52% to 26,232.46. The S&P 500 also
Avi Kapoor

Tue Sep 1, 2026

Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.58% to 52,876.43 while the NASDAQ dipped 1.40% to
Benzinga Newsdesk

Tue Sep 1, 2026

bioAffinity Technologies shares are trading higher after the company announced that it is advancing the potential application of its CyPath Lung Test.
Benzinga Insights

Tue Sep 1, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers bioAffinity Technologies (NASDAQ:BIAF) shares increased by 68.4% to $7.68 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.7 million. Lakewood-Amedex (NASDAQ:LABT)
Benzinga Newsdesk

Tue Sep 1, 2026

bioAffinity Technologies Advancing Potential Application Of Its CyPath Lung Test

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease, today announced that it is advancing the
Benzinga Newsdesk

Thu Aug 20, 2026

bioAffinity Technologies Announces 1-For-15 Reverse Stock Split, Effective Aug. 24

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it will effect a 1-for-15 reverse
Benzinga Insights

Wed Aug 19, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.6 million. As per the news, the Q2 earnings report came
Benzinga Newsdesk

Tue Aug 18, 2026

bioAffinity Technologies shares are trading higher after the company announced a distribution agreement with AvMEDICAL.
Benzinga Newsdesk

Tue Aug 18, 2026

bioAffinity Enters Into Distribution Agreement With AvMEDICAL Expanding bioAffinity's Commercial Reach Through AvMEDICAL's Existing Sales Team

New partner’s national sales force will market CyPath Lung to federal healthcare agencies, including VA medical centers nationwideAgreement significantly expands bioAffinity's commercial reach through
Benzinga Insights

Tue Aug 18, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.3 billion. bioAffinity Technologies